We have advised a start-up on the regulatory qualification and classification of its health application under the MDR, including the determination of whether the software qualifies as a medical device or as a wellness product.
Updates
Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.
Type
Sectors
Expertises (1)
57 results
Newest first
We have advised a laboratory on the regulatory status of laboratory developed tests (LDTs) under the IVDR.
We have assisted a diagnostics company with its companion diagnostics strategy, including the regulatory implications of combining diagnostic and therapeutic products.
We have advised an IVD manufacturer on a bringing companion diagnostic to market with respect to a patient support program.
Our team has advised an IVD-manufacturer on use of the inhouse-exemption under the IVDR.
We have supported an IVD manufacturer in the design and conduct of performance studies. We regularly advise clients on post-market performance follow-up (PMPF) obligations.
We have advised pharmacies on the regulatory aspects of pharmaceutical compounding.